Related Experiment Video

Updated: May 3, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications

Antonio Giovanni Richetta1, Valentina Silvestri, Simona Giancristoforo

  • 1Unit of Dermatology, Department of Internal Medicine and Medical Specialties, 'Sapienza' University of Rome, Rome, Italy.

Oncology
|January 25, 2014
PubMed

Insights

Melanoma tumors frequently exhibit multiple gene mutations. Assessing these mutations, including CDKN2A, can offer a genetic profile for prognosis and targeted therapy in melanocytic tumors.

Area of Science:

  • Oncology
  • Genetics
  • Dermatology

Background:

  • Melanoma tumorigenesis involves complex genetic alterations.
  • Targeted therapies require understanding specific gene mutations.

Purpose of the Study:

  • To analyze somatic mutations in 10 key genes in melanoma.
  • To evaluate the potential of mutation profiles as prognostic and therapeutic markers.

Main Methods:

  • Analysis of somatic mutations across 10 melanoma-relevant genes.
  • Assessment of mutation frequency and co-occurrence in tumor samples.

Main Results:

  • 45% of melanoma tumors analyzed had detectable mutations.
  • 33% of tumors displayed multiple mutations in the studied genes.
  • Specific gene mutation patterns were identified.

Conclusions:

  • Multiple gene mutations are common in melanoma.
  • Assessing mutation status, including CDKN2A, provides a valuable genetic profile.
  • This genetic profile can serve as a prognostic and therapeutic marker for melanocytic tumors.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

26.1K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K